JMP(R) Genomics Software from SAS Achieves GeneChip-compatible(TM) Status; Statistical Software Performs Whole Genome Association Studies with More Than 500,000 SNPs
BOSTON–(BUSINESS WIRE)–Aug. 8, 2006–SAS, the leader in business intelligence, today announced that two products in its suite of genomics software, JMP Microarray and JMP Genetics, earned GeneChip-compatible(TM) status for use with the Affymetrix microarray platform. This compatibility provides scientists who use GeneChip(R) expression and genotyping arrays with a seamless way to harness the power of SAS(R) to analyze data from their experiments and use the results to develop new drug therapies and applications.
JMP genomics software provides powerful and dynamic data visualization and statistical analysis desktop capabilities. The software uses SAS stored processes for unparalleled data processing and statistical capabilities.
High-content data presents data management and analysis challenges that interfere with efficient and accurate identification of genetic patterns and relationships. JMP genomics software overcomes many of these challenges by offering the capability to accurately and quickly determine data quality and statistical significance. The software also incorporates sophisticated statistical techniques that account for the effects of random factors.
Version 2.0.2 of the JMP suite of genomics software supports more than 90 SAS processes for genomic and proteomic molecular analyses and performs whole-genome association tests on datasets with more than 500,000 SNPs. In addition, it provides capabilities for chromosomal copy number and loss of heterozygosity analyses.
“Genomics discoveries require sophisticated analyses of almost overwhelming amounts of data. SAS is expert at handling and analyzing data. The JMP genomics products add interactive graphical tools that allow scientists to picture relationships and genomic areas of interest,” said Mike Lelivelt, Senior Manager of Informatics Applications at Affymetrix.
As a member of the Affymetrix GeneChip-compatible(TM) Applications Program, SAS commits to future technical integration between the JMP genomics software and GeneChip arrays as the Affymetrix platform evolves. For information about the JMP genomics software, visit www.jmp.com
About SAS
SAS is the leader in business intelligence software and services. Customers at 40,000 sites use SAS software to improve performance through insight into vast amounts of data, resulting in faster, more accurate business decisions; more profitable relationships with customers and suppliers; compliance with governmental regulations; research breakthroughs; and better products. Only SAS offers leading data integration, intelligence storage, advanced analytics and business intelligence applications within a comprehensive enterprise intelligence platform. Since 1976, SAS has been giving customers around the world The Power to Know(R). www.sas.com
About the Affymetrix Developers’ Network (ADN)
Through one of the largest third-party software developer communities within the life science industry, Affymetrix works with its software developers to provide a broad spectrum of solutions for leveraging gene expression and genetic variation analysis in both biomedical research and development. Membership in ADN is free of charge for both commercial and academic software developers. For more information please visit www.affymetrix.com/genechip/developer. View the GeneChip-compatible Software Solutions Catalog at www.affymetrix.com/genechip/compatible.
About Affymetrix
Affymetrix scientists invented the world’s first high-density microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip(R) technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world’s top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,400 systems have been installed around the world and nearly 4,000 peer-reviewed papers have been published using the technology. Affymetrix’ patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health. Affymetrix is headquartered in Santa Clara, Calif., with manufacturing facilities in Sacramento, Calif., and Bedford, Mass. The company maintains important sales and marketing operations in Europe and Asia and has about 1,100 employees worldwide. For more information about Affymetrix, please visit the company’s website at www.affymetrix.com.
SAS, JMP and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. (R) indicates USA registration. Other brand and product names are trademarks of their respective companies. Affymetrix, the Affymetrix logo, and GeneChip are registered trademarks owned or used by Affymetrix Inc.
